RevealDx Receives FDA Clearance for AI Powered Lung Nodule Risk Assessment
recent articles
Cytomine is thrilled to invite you to visit our company's booth at the upcoming Carrefour Pathologie Conference 2023, which takes place from 22 November until 24 November at the CNIT Forest Paris-La-Défense in Paris, France. Cytomine has...
GE Healthcare: New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatment. November 2, 2023 — GE HealthCare’s Artificial Intelligence (AI)...
Lunit: Six posters featuring the Lunit SCOPE suite and new insights into the tumor microenvironment are to be showcased at the SITC 2023 Annual Meeting SEOUL, South Korea, Nov. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading...
Gestalt and Pramana: Collaboration Brings DICOM, AI, Image Analysis, and Digital Pathology in Single, Streamlined, Comprehensive Offering SPOKANE, Wash. and CAMBRIDGE, Mass., Oct. 23, 2023 /PRNewswire/ -- Gestalt Diagnostics, Inc., a...
Aiforia empowers pathologists and scientists in both preclinical and clinical laboratories by delivering robust, deep-learning artificial intelligence software designed to transform images into powerful revelations, informed decisions,...
Spokane, WA, - October 30, 2023 – Gestalt has been named in the Top 10 Healthcare Solution Providers for the third year in a row by Global Healthcare Outlook. Global Healthcare Outlook publishes an annual listing of the Top 10...
